Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Cerebral Vasospasm in SAH
NCT00871065Phase 2Withdrawn
- Sponsor
- University of Nebraska
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of sildenafil in cerebral vasospasm, sponsored by University of Nebraska. Primary endpoint: Onset of cerebral vasospasm. Planned start Jul 2008; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
cerebral vasospasm
Beyond the preview
Go deeper on NCT00871065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00871065.